Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM
Clinical trial NCT01114282 · COMPLETED
Trial details
- NCT number
- NCT01114282
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2014-02-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.